-
- Hirasawa Akira
- Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
-
- Hara Takafumi
- Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
-
- Katsuma Susumu
- Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
-
- Adachi Tetsuya
- Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
-
- Tsujimoto Gozoh
- Department of Genomic Drug Discovery Science, Kyoto University Graduate School of Pharmaceutical Sciences
この論文をさがす
抄録
Utilizing the human genome database, the recently developed G-protein-coupled receptor (GPCR) deorphanizing strategy successfully identified multiple receptors of free fatty acids (FFAs) and is proposed to play a critical role in a variety of physiologic homeostasis mechanisms. GPR40 and GPR120 are activated by medium- and long-chain FFAs, whereas GPR41 and GPR43 are activated by short-chain FFAs. GPR40, which is preferentially expressed in pancreatic β-cells, mediates insulin secretion. On the other hand, GPR120, which is abundantly expressed in the intestine, functions as a receptor for unsaturated long-chain FFAs and promotes the secretion of glucagon-like peptide-1 (GLP-1). In this review, we summarize the identification, structure, and pharmacology of the receptors and speculate on the respective physiologic roles that FFA receptor family members may play.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 31 (10), 1847-1851, 2008
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204624206720
-
- NII論文ID
- 110006936320
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 9655255
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可